Connection

Olga Brawman-Mintzer to Clinical Trials, Phase III as Topic

Back to Details
This is a "connection" page, showing publications Olga Brawman-Mintzer has written about Clinical Trials, Phase III as Topic.
Olga Brawman-Mintzer
Connection Strength
0.036
Clinical Trials, Phase III as Topic
  1. The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial. Trials. 2018 Jan 18; 19(1):46.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.